GeneDx
Katherine Stueland is an accomplished healthcare executive with extensive experience in transforming patient care through innovative business strategies. As the Chief Executive Officer at GeneDx since June 2021, Katherine has continued a distinguished career that includes serving as Chief Commercial Officer at Invitae from November 2013 to June 2021, where oversight of the commercial organization led to remarkable test volume and revenue growth. Prior roles include Vice President at Dendreon Corporation and Director at WCG, where Katherine provided strategic counsel across media, investor relations, and public communications. Katherine's career highlights also encompass roles at TAP Pharmaceutical Products Inc., Prescott Medical Communications, and Weber Shandwick, contributing to various high-stakes initiatives in healthcare communications. Katherine holds a Bachelor’s degree in science and English literature from Miami University, earned in 1997.
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.